Hikal Limited (NSE:HIKAL)
India · Delayed Price · Currency is INR 255.80
-12.40 (-4.62%)
Aug 13, 2025, 3:30 PM IST
Hikal Market Cap
Hikal has a market cap or net worth of 33.07 billion as of August 13, 2025. Its market cap has decreased by -24.87% in one year.
Market Cap
33.07B
Enterprise Value
40.54B
Revenue
18.33B
Ranking
n/a
PE Ratio
52.24
Stock Price
255.80
Market Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 33.07B, an increase of 2,336.57%. That is a compound annual growth rate of 14.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 33.07B | -31.23% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | 20.31B | 44.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,859.09B |
| Divi's Laboratories | 1,590.69B |
| Cipla | 1,215.50B |
| Apollo Hospitals Enterprise | 1,043.73B |
| Mankind Pharma | 1,006.03B |
| Zydus Lifesciences | 961.51B |
| Fortis Healthcare | 695.05B |
| Aurobindo Pharma | 611.53B |